T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
AXIS 2: AX200 for the Treatment of Ischemic Stroke
- Status
- COMPLETED
- Phase
- PHASE2
Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2
Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease
- Status
- TERMINATED
- Phase
- PHASE2
Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery
- Status
- UNKNOWN
- Phase
- PHASE1
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- Status
- RECRUITING
- Phase
- PHASE3
G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE1